The abstract shows T3 and sobetirome protect oligodendrocytes against cell death in culture and preserve oligodendrocyte numbers in EAE, but the specific cellular pathways mediating this neuroprotection are not identified. Understanding these mechanisms is critical for developing targeted therapies for multiple sclerosis and other demyelinating diseases. Gap type: unexplained_observation Source paper: Thyroid hormone and thyromimetics inhibit myelin and axonal degeneration and oligodendrocyte loss in EAE. (2021, Journal of neuroimmunology, PMID:33422763)
Landscape Summary: What are the molecular mechanisms by which thyromimetics prevent oligodendrocyte death in neuroinflammation? is a 0.82 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
What are the molecular mechanisms by which thyromimetics prevent oligodendrocyte death in neuroinflammation? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No knowledge graph edges recorded
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: